Prof. Nir Barzilai

Nir Barzilai is a geroscientist, chaired Professor of Medicine and Genetics, the founder and the principal investigator of the Einstein Nathan Shock Center and the Glenn Center for excellence in Biology of Aging. He studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He also leads the TAME (Targeting/Taming Aging with Metformin) to prove to the FDA that aging can be delayed and to allow for next-generation interventions (https://www.afar.org/tame-trial). He has authored over 300 peer-reviewed papers and was a recipient of numerous prestigious awards, including the 2010 Irving S. Wright Award for Distinction in Aging Research and the 2018 recipient of the IPSEN Longevity award.  He is on the board of AFAR, and its scientific director and a founding member of the Academy for Healthspan and Lifespan, The Longevity Biotech Association, and the Healthy Longevity Medicine Society. He co-founded CohBar and Lifebiosciences. He is featured in prominent papers, podcasts, TV programs, documentaries, TED talks, consulting for the Singapore government, several International Banks, The Vatican, Milken Institute, and Davos Economic Forum. His book Age Later was published in June 2020.